CI
CL icon

CX Institutional’s Colgate-Palmolive CL Stock Holding History

CX Institutional’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.21M Buy
14,150
+1,509
+12% +$137K 0.03% 317
2026
Q2 		$1.16M Sell
12,641
-675
-5% -$59.1K 0.03% 314
2026
Q1 		$1.14M Sell
13,316
-78,946
-86% -$7.04M 0.03% 320
2025
Q4 		$7.29M Buy
92,262
+15,983
+21% +$1.25M 0.22% 124
2025
Q3 		$6.1M Buy
76,279
+14,137
+23% +$1.21M 0.19% 132
2025
Q2 		$5.65M Buy
62,142
+2,856
+5% +$261K 0.2% 130
2025
Q1 		$5.55M Buy
59,286
+54,747
+1,206% +$4.9M 0.21% 114
2024
Q4 		$413K Buy
4,539
+340
+8% +$32.4K 0.02% 376
2024
Q3 		$436K Sell
4,199
-216
-5% -$22K 0.02% 387
2024
Q2 		$428K Sell
4,415
-21
-0.5% -$1.94K 0.02% 387
2024
Q1 		$399K Buy
4,436
+20
+0.5% +$1.7K 0.02% 400
2023
Q4 		$352K Sell
4,416
-2,236
-34% -$168K 0.02% 375
2023
Q3 		$473K Buy
6,652
+16
+0.2% +$1.2K 0.03% 335
2023
Q2 		$511K Buy
6,636
+327
+5% +$25.3K 0.03% 344
2023
Q1 		$475K Sell
6,309
-43,048
-87% -$3.2M 0.03% 351
2022
Q4 		$3.89M Buy
+49,357
New +$3.7M 0.24% 116
2022
Q3 		– Sell
-11,589
Closed -$929K – 579
2022
Q2 		$929K Buy
11,589
+2,943
+34% +$230K 0.07% 247
2022
Q1 		$656K Sell
8,646
-35,300
-80% -$2.8M 0.05% 254
2021
Q4 		$3.75M Buy
43,946
+19,328
+79% +$1.51M 0.3% 102
2021
Q3 		$1.86M Buy
24,618
+201
+0.8% +$16K 0.15% 155
2021
Q2 		$1.99M Buy
24,417
+741
+3% +$60.6K 0.16% 154
2021
Q1 		$1.87M Buy
23,676
+22,029
+1,338% +$1.73M 0.17% 162
2020
Q4 		$141K Sell
1,647
-338
-17% -$27.9K 0.01% 318
2020
Q3 		$153K Buy
1,985
+615
+45% +$46.9K 0.02% 276
2020
Q2 		$100K Buy
1,370
+600
+78% +$42.6K 0.01% 290
2020
Q1 		$51K Sell
770
-117
-13% -$8.25K 0.01% 310
2019
Q4 		$61K Sell
887
-581
-40% -$39.6K 0.01% 266
2019
Q3 		$108K Sell
1,468
-148
-9% -$10.7K 0.02% 240
2019
Q2 		$116K Sell
1,616
-1,516
-48% -$108K 0.02% 259
2019
Q1 		$215K Buy
3,132
+2,978
+1,934% +$192K 0.04% 208
2018
Q4 		$9K Buy
+154
New +$9.63K ﹤0.01% 357

Other funds holding CL

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

CX Institutional's CL Position: Q3 2026 in Review

CX Institutional increased its Colgate-Palmolive (CL) stake by 12% in Q3 2026, buying an estimated $137K and bringing the position to 14,150 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #317.

CX Institutional first reported a position in CL in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.29M in Q4 2025. 106 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • CX Institutional held 14,150 shares of Colgate-Palmolive worth $1.21M as of Q3 2026.
  • CX Institutional bought 1,509 Colgate-Palmolive shares in Q3 2026, an estimated $137K.
  • Colgate-Palmolive made up 0.03% of CX Institutional's portfolio in Q3 2026, its #317 holding.
  • CX Institutional first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 31 quarters since.
  • CX Institutional's Colgate-Palmolive position peaked at $7.29M in Q4 2025.
  • 106 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.